Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAzienda Ospedaliero-Universitaria di Modena

About this trial

Considering the high prevalence of cardiovascular disease in Turner syndrome patients, noninvasive cardiac imaging is crucial for diagnosis and follow-up. From the review of the literature, it was evident that the imaging techniques used involved the evaluation of only the thoracic findings, in particular the heart and the thoracic aorta, while no data are currently available on the distal abdominal aorta or iliac arteries, since ultrasound and MRI are interrupted at the diaphragmatic level.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

confirmed diagnosis of Turner Syndrome

patients underwent angioMR 1.5 T

age > 18 years

Disqualifiers

None

Trial population

cohort of patients with Turner syndrome \> 18 years

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • imaging

    Diagnostic test

    cardiac angioMR

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Vascular and cardiac anomalies

description of the main cardiovascular anomalies found by MRI at the thoracic and abdominal level anomalies in terms of supernumeray arteries and/or veins and measurement of length and diameters of main vascular tracts (e.g. ascending, descending aorta, aortic arch, renal arteries...) or vascular congenital abnormalities

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.